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Abstract
Backgrounds: Reduced left ventricular ejection fraction (LVEF) after acute myocardial infarction (AMI), which implies
the occurrence of cardiac dysfunction, impacts cardiac prognosis, even after primary percutaneous coronary
intervention (PCI). This study was designed to clarify the difference of clinical and angiographic predictors for
reduced LVEF in ST-elevation myocardial infarction (STEMI) patients with left anterior descending artery (LAD) or
non-LAD vessel as culprit artery.
Methods: This was a retrospective study to review a total of 553 patients of STEMI underwent primary PCI in our
hospital. All patients underwent echocardiography. Univariate analysis, multivariate analysis and classification and
regression tree (CART) were performed between LAD related AMI and non-LAD related STEMI. The primary
outcome was the occurrence of reduced LVEF 4–6 days after PCI.
Results: In this study, culprit arteries of STEMI were 315 in LAD system (6 in left main artery, 309 in LAD) and 238 in
non-LAD system (63 in left circumflex and 175 in right coronary artery). Compared with non-LAD group, post-MI
LVEF was significantly reduced in LAD related STEMI group (52.4 ± 9.3 % vs. 57.1 ± 7.8 %, P < 0.01). Multivariate
analysis indicated that elder (>65 years), time to hospital and proximal occlusion were associated with reduced
LVEF (<55 %) in LAD related STEMI patients. However, in non-LAD patients, time to hospital, multivessel stenosis
and post-PCI blood pressure predicted the occurrence of reduced LVEF. Furthermore, CART analysis also obtained
similar findings.
Conclusions: Patients with LAD or non-LAD related STEMI could suffer reduced LVEF, while the clinical and
angiographic predictors for the occurrence were different.
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Background
Reduced left ventricular ejection fraction (LVEF), which
is significantly associated with cardiac dysfunction, oc-
curs approximately in 30–40 % of patients who suffer
ST-elevation myocardial infarction (STEMI). Although
the incidence of reduced LVEF after STEMI declined
significantly [1] because of great advancement in the
treatment of anti-thrombotic therapy and primary per-
cutaneous coronary intervention (PCI), it is still one of
most critical complications after STEMI that carries a
poor cardiac prognosis [2–7]. Reduced LVEF, which is
common in STEMI patients with left main artery (LM)
or left anterior descending artery (LAD) as culprit vessel.
The occurrence was related to older ages, hypertension,
diabetes [1], time to reperfusion [8], and higher preva-
lence of proximal occlusion [9]. The extent of acute
myocardial damage in LAD occlusion is markedly larger
than that in either left circumflex (LCX) or right coron-
ary artery (RCA) occlusion. However, it has been also re-
ported that reduced LVEF or cardiac dysfunction
occurred in STEMI patients with RCA or LCX as culprit
vessel [10, 11]. However, it was unclear whether there
were predictors difference for reduced LVEF between
LAD-related and non-LAD-related STEMI.
Given to the impact of new-onset cardiac dysfunction
after STEMI on the cardiac prognosis, it is important to
investigate the difference of clinical and angiographic
predictors for reduced LVEF in STEMI patients with dif-
ferent culprit vessels. These findings will provide rapid
prediction and beneficial effects on the early prevention
of cardiac dysfunction after STEMI.
Methods
Study population
This was a retrospective clinical study to review the pa-
tients of acute STEMI underwent primary PCI (n = 664)
in our hospital from Jul 2011 to Oct 2013. Baseline 12-
lead electrocardiograms were performed at admission. A
total of 553 patients were included in this study, while
111 patients were excluded according to follow exclusion
criteria. The inclusion criteria were: (1) patients with 18
to 85 years of age; (2) diagnosed as acute STEMI; (3)
underwent primary coronary intervention within 12 h
after chest pain on-set. The exclusion criteria were as
follows: (1) incomplete clinical history record (n = 23);
(2) excluded the diagnosis of myocardial infarction by
angiography, such as viral myocarditis, pericarditis or
cardiomyopathy (n = 26); (3) not finish the detection of
echocardiography in-hospitalization because of any
reason (n = 17); (4) confirmed clinical heart failure be-
fore this admission, complicated with cardiomyopathy,
congenital heart diseases and rheumatic heart disease
(n = 19); (5) active chronic inflammation (n = 14); (6)
dysfunction of hematological and immunological
system (n = 4); (7) carcinoma or a condition treated
with immunosuppressive agents (n = 8). This study
and consent procedure were approved by our local
ethics committee (Ethics Committee of Zhongshan
Hospital affiliated to Fudan University), and were car-
ried out in accordance with the principles of the Dec-
laration of Helsinki. Consent for publication of these
data was obtained from each patient when they were
admitted in our hospital.
Several important clinical variables were record, such
as age, gender, hypertension, diabetes, stable angina his-
tory, Time to hospital (from chest pain on-set to diagno-
sis) and D-to-B time (door to balloon).
Primary percutaneous coronary intervention
Prior to primary PCI, all patients received adequate
loading doses of aspirin (300 mg) and clopidogrel
(300 mg) or ticagrelor (180 mg) immediately after diag-
nosed as STEMI. Procedure of PCI was performed im-
mediately via the femoral or radial access route. The
characteristics of coronary angiography were record,
such as culprit artery, acute occlusive segment and
multi-vessel disease (defined as having at least another
vessel with 75 % or greater stenosis except the culprit
occlusion artery, such as culprit vessel in LAD had LCX
or RCA or LM stenosis, culprit vessel in LCX had RCA
or LAD or LM stenosis, culprit vessel in RCA had LCX
or LAD or LM stenosis). A lesion was considered prox-
imal if it was located proximal to the first diagonal
branch in the LAD, the first obtuse marginal branch in
LCX, or the first acute marginal branch in RCA [12].
The usages of interventional techniques, thrombus as-
piration and platelet glycoprotein IIb/IIIa receptor in-
hibitor were chosen at the operators’ discretion. The
phenomenon of no reflow or slow flow post-stenting
was record. Post-PCI blood pressure, including systolic
blood pressure (SBP) and diastolic blood pressure
(DBP), was detected by invasive blood pressure monitor
from radial or femoral vascular sheaths.
Echocardiography
Echocardiography was performed before discharge (4–6
days post-PCI) in all patients using a Philips IE33 instru-
ment (Philips, Netherlands) with a 2–3.5 MHz trans-
ducer (X3-1), while left ventricular ejection fraction
(LVEF) were detected by Simpson method. It was de-
fined as reduced LVEF while LVEF less than 55 %. All
exams were performed by one of three echocardiography
operators. These three operators underwent standard-
ized training before this study. Observers who detected
LVEF were blinded to the results of coronary angiog-
raphy and clinical record. The incidence of reduced
LVEF after STEMI was compared between two different
culprit artery systems, including LAD related STEMI
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(LM occlusion and LAD occlusion, n = 315) and non-
LAD related STEMI (LCX occlusion, n = 63; RCA occlu-
sion, n = 175).
Statistical Analysis
All statistical analyses were performed with SPSS soft-
ware 19.0. Data were presented as the percentage or
mean ± standard deviation (SD). Chi-square analysis was
used to compare the frequency for categorical variables,
and Student’s t or correction t tests were used to com-
pare means for continuous variables. Multivariable logis-
tic analysis was performed to identify the independent
risk factors for reduced LVEF (LVEF < 55 %). Stratifica-
tion according to different risk subsets was also made by
classification and regression tree (CART) analysis. All P-
values were two-sided, and P < 0.05 was considered to
indicate statistical significance.
Results
Clinical and angiographic characteristics
A total of 553 STEMI patients enrolled with average age
64.0 ± 12.0 years. There were 447 men (80.8 %) and 106
women (19.2 %). The prevalence of hypertension and
diabetes were 60.4 % (334 patients) and 48.8 % (270 pa-
tients), respectively. Culprit arteries of STEMI were 6 in
LM, 309 in LAD, 63 in LCX and 175 in RCA, respect-
ively. Baseline clinical and angiographic characteristics
of patients with different culprit arteries were shown in
Table 1. Compared with the non-LAD related STEMI
(culprit arteries were RCA and LCX), patients of LAD
related STEMI (culprit arteries were LM and LAD) had
lower LVEF (52.4 ± 9.3 % vs. 57.1 ± 7.8 %, P < 0.01) and
higher incidence of reduced LVEF (LVEF < 55 %: 53.7
and 26.9 %, P < 0.01).
Reduced LVEF and predictor analysis
In order to clarify the predictor difference for reduced
LVEF in LAD system and non-LAD system groups, sev-
eral clinical and angiographic predictors were analyzed
by univariate analysis, shown in Table 1 and Fig. 1. It
was demonstrated that elder (more than 65 years), time
to hospital (from chest pain on-set to diagnosis), acute
occlusion in proximal segment and post-PCI blood
pressure significantly increased the risk of reduced in
LAD system. However, in non-LAD related STEMI pa-
tients, beside the factors of age and time to hospital,
Table 1 Comparison of clinical and angiographic characteristics among STEMI patients with different culprit vessel
LAD system (n = 315) Non-LAD system (n = 238)
EF < 55 % EF≥ 55 % P EF < 55 % EF≥ 55 % P
n = 169 n = 146 n = 64 n = 174
(1) Clinical characteristics
Male (%) 133 (78.7 %) 121 (82.9 %) 0.349 54 (84.4 %) 139 (79.9 %) 0.433
Age (years) 65.4 ± 11.4 60.7 ± 12.7 <0.01 67.4 ± 11.9 63.9 ± 11.3 0.034
Hypertension (%) 98 (58.7 %) 82 (56.6 %) 0.704 40 (62.5 %) 114 (65.9 %) 0.627
Diabetes (%) 94 (55.6 %) 68 (46.6 %) 0.098 29 (45.3 %) 79 (45.7 %) 0.961
Stable angina history (%) 58 (34.3) 59 (40.4 %) 0.265 25 (39.1 %) 62 (35.6 %) 0.626
Time to hospital (hours) 6.0 ± 2.5 5.3 ± 2.7 <0.01 6.6 ± 2.7 5.3 ± 2.4 <0.01
D-to-B time (minutes) 76.2 ± 27.4 74.6 ± 25.6 0.675 71.2 ± 21.3 74.3 ± 22.7 0.304
(2) Angiographic characteristics
Number of disease vessels 1.8 ± 0.8 1.6 ± 0.8 0.197 2.2 ± 0.8 1.9 ± 0.8 0.061
Multi-vessel stenosis (%) 94 (55.6 %) 66 (45.2 %) 0.065 47 (73.4 %) 100 (57.5 %) 0.025
–two vessels disease (including culprit vessel) 56 35 19 51
–three vessels disease (including culprit vessel) 38 31 28 49
–LAD AMI complicated with LCX stenosis 64 46 – –
–LAD AMI complicated with RCA stenosis 68 51 – –
–non-LAD AMI complicated with LAD stenosis – – 24 48
Occlusion in proximal segment (%) 101 (59.8 %) 70 (47.9 %) 0.036 21 (32.8 %) 57 (32.8) 0.994
Slow or no reflow (%) 34 (20.1 %) 26 (17.8 %) 0.603 12 (18.8 %) 20 (11.5 %) 0.146
Post-PCI SBP (mmHg) 114.5 ± 16.8 119.2 ± 16.7 0.014 110.7 ± 18.7 113.1 ± 16.5 0.368
Post-PCI DBP (mmHg) 70.7 ± 9.1 72.9 ± 7.7 0.027 68.5 ± 11.0 70.9 ± 9.0 0.123
LAD system STEMI in left main or left main artery or left anterior descending artery; Non-LAD system STEMI in left circumflex or right coronary artery;
DBP diastolic blood pressure; D-to-B door to balloon; SBP systolic blood pressure;
STEMI ST-Elevation Myocardial Infarction; Time to hospital: from chest pain on-set to diagnosis;
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multivessel stenosis significantly increased the risk of re-
duced LVEF. In order to further clarify the influence of
post-PCI blood pressure, the occurrence of reduced
LVEF was analyzed among four groups classified by the
quartile of post-PCI blood pressure in patients with
LAD system or non-LAD system STEMI, shown in
Fig. 2. We found that lower SBP and DBP after primary
PCI predicted the higher risk of reduced LVEF.
Multivariate analysis
Multivariate logistic analysis was performed to demon-
strate the independent effect of these predictors (con-
firmed statistic difference in univariate analysis) on the
occurrence of reduced LVEF after STEMI, In this ana-
lysis, reduced LVEF (LVEF < 55 %) was employed as a
dependent variable in both LAD and non-LAD system
subgroups, while age > 65 years, multi-vessel stenosis,
acute occlusion in proximal segment, time to hospital,
post-PCI SBP <100 mmHg and post DBP <65 mmHg
were set as independent variables, shown in Table 2.
These results demonstrated that elder (OR = 1.984, 95 %
CI = 1.205–3.266, P < 0.01), proximal occlusion (OR =
1.681, 95 % CI = 1.042–2.713, P = 0.033) and time to
hospital (OR = 1.106, 95 % CI = 1.010–1.210, P = 0.029)
were major independent predictors for reduced LVEF in
LAD system, while time to hospital (OR = 1.246, 95 %
CI = 1.097–1.414, P < 0.01), multi-vessel stenosis (OR =
2.394, 95 % CI = 1.185–4.836, P = 0.015) and post-PCI
SBP < 100 mmHg (OR = 2.927, 95 % CI = 1.052121–
7.643, P = 0.028) in non-LAD system.
CART analysis
In order to confirm the impact of predictors on reduced
LVEF and simply the prediction process, CART analysis
was also applied to assess the incidence of reduced LVEF
after STEMI in multivariate subgroups. Reduced LVEF
was employed as a dependent variable, while age >
65 years, male gender, stable angina history, diabetes,
hypertension, culprit vessel (LAD system or non-LAD
system), time to hospital >5 h, multi-vessel stenosis, oc-
clusion in proximal segment, slow or no reflow, post-
PCI SBP <100 mmHg and post DBP < 65 mmHg were
set as independent variables. CART analysis results were
shown in Fig. 3. We found that LAD system was the
major determinant of reduced LVEF after STEMI. Beside
culprit artery, elder, time to hospital > 5 h and proximal
Fig. 1 Subgroups analysis of clinical and angiographic factors for the increasing risk of reduced LVEF (LVEF < 55 %) in LAD and non-LAD related
STEMI groups
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occlusion were most critical three steps in risk stratifica-
tion for reduced LVEF in LAD system, while time to
hospital and post-PCI diastolic blood pressure <
60 mmHg in non-LAD system.
Discussion
Acute myocardial infarction (AMI), which is mostly
caused by coronary plaque rupture or erosion, could re-
sult in several clinical complications and impact cardiac
prognosis [4, 13]. Reduce LVEF or cardiac dysfunction
occurs approximately in 30–40 % of patients who suffer
STEMI, and the mortality of patients with post-MI car-
diac dysfunction is 20 to 30 % [7]. As we know, reduced
LVEF was common in STEMI patients with LM or LAD
as culprit vessel. It has also been reported that re-
duced LVEF could occurred in patients with RCA or
LCX as culprit vessel [10, 11, 14]. However, there were
few studies focused on the risk factors or clinical predic-
tors for reduced LVEF caused by RCA or LCX-related MI.
Furthermore, it was unclear whether there were different
clinical and angiographic characteristics between LAD
and non-LAD-related STEMI with reduced LVEF.
In this study, we confirmed the occurrence of reduced
LVEF (LVEF < 55 %) in non-LAD related MI patients,
although this prevalence was lower than that in LAD
related MI group (26.9 vs. 53.7 %, P < 0.01). In order to
clarify the difference of predictors between these two
different culprit vessels, sub-group analyses and multi-
variate logistic analysis were also performed. We
found that elder age, Time to hospital and proximal
occlusion were critical for reduced LVEF in LAD related
STEMI, while multi-vessel stenosis, Time to hospital
Fig. 2 LAD system: STEMI in left main or left main artery or left anterior descending artery; Non-LAD system: STEMI in left circumflex or right cor-
onary artery; DBP: diastolic blood pressure; SBP: systolic blood pressure; Groups A to D indicated four groups classified by the quartile of post-PCI
blood pressure SBP: group A: <102mmHg; Group B: 103-110mmHg; Group C: 111-120mmHg; Group D: >120mmHg DBP: group A: <65mmHg;
Group B: 66-70mmHg; Group C: 71-78mmHg; Group D: >79mmHg. The incidence of reduced LVEF in different post-PCI blood pressure subgroups
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and post-PCI blood pressure contributed most to re-
duce LVEF in non-LAD related STEMI.
De Luca G reported [15] that elderly patients complicated
with higher incidence of hypertension and diabetes, more
advanced Killip class at presentation, longer time to treat-
ment, higher prevalence of distal embolization and signifi-
cantly impaired myocardial perfusion, which resulted in
worse coronary microcirculation and higher mortality after
STEMI [16], even undergoing primary angioplasty. Previ-
ously, few studies reported the different impact of older age
on cardiac dysfunction between LAD and non-LAD related
STEMI. In the LAD related MI, significantly impaired
microcirculation and proximal occlusion directly resulted
in more severe ischemia and large area of infarction, which
Table 2 Odds ratios of independent predictors for reduced LVEF after STEMI in LAD and non-LAD system (multivariate logistic
analysis)
Predictors OR 95 % confidence intervals P
LAD system
Elder (>65 years) 1.984 1.205–3.266 <0.01
Proximal occlusion 1.681 1.042–2.713 0.033
Time to hospital 1.106 1.010–1.210 0.029
Multi-vessel stenosis 1.395 0.848–2.296 0.190
Post-PCI SBP < 100 mmHg 1.563 0.540–4.521 0.410
Post-PCI DBP < 60 mmHg 1.677 0.778–3.613 0.187
Non-LAD system
Elder (>65 years) 1.167 0.616–2.209 0.635
Proximal occlusion 1.108 0.569–2.159 0.762
Time to hospital 1.246 1.097–1.414 <0.01
Multi-vessel stenosis 2.394 1.185–4.836 0.015
Post-PCI SBP < 100 mmHg 2.927 1.121–7.643 0.028
Post-PCI DBP < 60 mmHg 1.778 0.792–3.988 0.163
LAD system STEMI in left main or left main artery or left anterior descending artery;
Non-LAD system STEMI in left circumflex or right coronary artery;
DBP diastolic blood pressure; SBP systolic blood pressure;
STEMI ST-Elevation Myocardial Infarction;
Time to hospital: from chest pain on-set to diagnosis
Fig. 3 CART analysis demonstrated the major predictors and diagnostic steps for reduced LVEF
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exacerbated left ventricular systolic dysfunction. However,
on the contrary, the extent of myocardial perfusion injury
in non-LAD vessels contributes less to the left ventricular
systolic function. In the non-LAD related MI, multivessel
stenosis, which contained LAD stenosis, was more import-
ant for left ventricular function.
Hypertension has also been one of well-established
factors for increasing risk of cardiovascular diseases,
such as acute myocardial infarction and heart failure
[17]. Meanwhile, low admission blood pressure in MI
patients has been suggested as a predictor for cardiac
mortality [18]. However, it was unclear about the pre-
dictive value of post-PCI blood pressure on the risk of
reduced LVEF between different culprit arteries. In our
study, we found that lower post-PCI systolic
(<100 mmHg) or diastolic (<60 mmHg) blood pressure
indicated the higher incidence of reduced LVEF (Fig. 2).
After adjusted by other factors, post-PCI systolic blood
pressure was also independently associated with cardiac
dysfunction in non-LAD related MI.
As we know, reperfusion time to STEMI is one of the
most important factors for short- and long-term cardiac
prognosis [19]. In our study, there was no significant dif-
ference of D-to-B time between cardiac dysfunction and
preserved function groups. However, time from chest
pain on-set to diagnosis, defined as Time to hospital,
was quite different between these two groups. As dem-
onstrated in multivariable analysis, STEMI patients with
Time to hospital more than 5 h had less LVEF no matter
in LAD or non-LAD related STEMI groups, which could
be resulted in more injured cardiomyocytes and higher
risk of cardiac complications. CART analysis, which was
analyzed based different risk factors’ subgroups, indi-
cated rapid prediction for the occurrence of reduced
LVEF.
We should note some of our study’s limitations. First,
the number of included patients was small size. Second,
its retrospective nature limited its potency to clarify the
cause relation between predictions and reduced LVEF.
Third, the inclusion of LVEF in this study was only
short-term data, therefore, long-term data will be needed
to document the association between predictors and
post-PCI LVEF. These limitations will be taken into ac-
count in our further clinical researches and prospective
studies.
Conclusions
Patients with LAD or non-LAD related STEMI could
suffer reduced LVEF, while the clinical and angiographic
predictors for the occurrence were quite different.
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